Hyperfine (HYPR) Debt Ratio (2020 - 2026)

Hyperfine (HYPR) reported Debt Ratio of 0.22 for Q1 2026, up 41393.29% quarter-over-quarter from 0.0 in Q1 2023.

Hyperfine (HYPR) Debt Ratio (2020 - 2026) Analysis & Trends

Hyperfine has reported Debt Ratio for 5 years, with the latest figure at 0.22 in Q1 2026.

For the quarter ending Q1 2026, Debt Ratio changed N/A year-over-year to 0.22; the trailing twelve-month figure through Mar 2026 stood at 0.22 (changed N/A YoY), and the FY2021 full-year result was 0.01, up 122.87% from the prior year.
Debt Ratio for Q1 2026 stood at 0.22, up from 0.0 in the prior quarter.
The five-year high for Debt Ratio was 0.22 in Q1 2026, with the low at 0.0 in Q3 2022.
Historically, Debt Ratio has averaged 0.04 across 3 years, with a median of 0.0 in 2023.
The largest YoY upside for Debt Ratio was 3.37% in 2023 against a maximum downside of 3.37% in 2023.
Hyperfine's Debt Ratio stood at 0.0 in 2022, then advanced by 27.46% to 0.0 in 2023, then surged by 41393.29% to 0.22 in 2026.
The last three Debt Ratio figures came in at 0.22 (Q1 2026), 0.0 (Q1 2023), and 0.0 (Q3 2022), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	0.31
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	0.32
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	0.31
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	0.25
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	0.04
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.30
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	0.27
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	0.18
10	Hyperfine	155.82 Mn	114.55 Mn	1.98 Mn	0.22

Download Data